Chroma granted Cell Therapeutics exclusive rights in North, Central and South America to co-develop and commercialize cancer candidate tosedostat

Chroma Therapeutics Ltd.

U.K. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cell Therapeutics Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$334.4m on 03/18/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Terminated

Sample

01/01/2009

announced

01/01/2009

Terminated